Leineweber, C.G.; Pietzner, A.; Zhang, I.W.; Blessin, U.B.; Rothe, M.; Schott, E.; Schebb, N.H.; Weylandt, K.H.
Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma. Int. J. Mol. Sci. 2020, 21, 1875.
https://doi.org/10.3390/ijms21051875
AMA Style
Leineweber CG, Pietzner A, Zhang IW, Blessin UB, Rothe M, Schott E, Schebb NH, Weylandt KH.
Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2020; 21(5):1875.
https://doi.org/10.3390/ijms21051875
Chicago/Turabian Style
Leineweber, Can G., Anne Pietzner, Ingrid W. Zhang, Usha B. Blessin, Michael Rothe, Eckart Schott, Nils H. Schebb, and Karsten H. Weylandt.
2020. "Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma" International Journal of Molecular Sciences 21, no. 5: 1875.
https://doi.org/10.3390/ijms21051875
APA Style
Leineweber, C. G., Pietzner, A., Zhang, I. W., Blessin, U. B., Rothe, M., Schott, E., Schebb, N. H., & Weylandt, K. H.
(2020). Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences, 21(5), 1875.
https://doi.org/10.3390/ijms21051875
